First human GLP-1 gene therapy trial gets green light
Summary
A new gene therapy that targets the GLP-1 hormone is about to be tested in humans for the first time. This therapy aims to treat obesity and Type 2 diabetes by using the body’s own mechanisms to control weight and blood sugar.Key Facts
- GLP-1 is a hormone involved in regulating appetite and blood sugar.
- Medicines based on GLP-1 have helped many people with obesity and Type 2 diabetes.
- The new therapy uses gene therapy, which involves changing genes to treat diseases.
- This will be the first time the GLP-1 gene therapy is tested in human trials.
- The goal is to create a long-lasting treatment for obesity and diabetes by making the body produce GLP-1 on its own.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.